NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine - https://archive.org/web/.

Categories: Drug costs

1/26/2016

New drug candidate yields “significant weight loss” — but what does that mean?

11/10/2015

Get paid to take your pills? Strong Inquirer report covers all the ins and outs

11/2/2015

Coverage of virus-based cancer treatment skimps on cautions and key outcomes

5 10/28/2015

News release-based story on cancer drug lacks most of what readers need

6/2/2015

Keytruda and colon cancer: coverage of benefits not balanced with harms and cost info